| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | +111.4% |
| Cost of Revenue | $1.9M | +101.5% |
| Gross Profit | -$503K | -79.0% |
| R&D Expense | $1.5M | +3.3% |
| SG&A Expense | $6.4M | -9.3% |
| Operating Income | -$9.7M | -0.6% |
| Pre-tax Income | -$2.8M | +72.4% |
| Income Tax | $1K | -50.0% |
| Net Income | -$2.8M | +72.3% |
| EPS (Basic) | -$0.06 | +83.3% |
| EPS (Diluted) | -$0.06 | +83.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $585K | +240.1% |
| Accounts Receivable | $495K | +132.4% |
| Current Assets | $2.1M | -42.1% |
| Total Assets | $2.2M | -42.3% |
| Current Liabilities | $4.8M | -74.9% |
| Long-term Debt | $220K | -90.5% |
| Total Liabilities | $5.1M | -74.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.5M | -7.4% |
| Capital Expenditures | $13K | -74.5% |
| Investing Cash Flow | $2.3M | +216.4% |
| Financing Cash Flow | $5.6M | -38.3% |
| Free Cash Flow | -$7.5M | -6.9% |
| -$3.0M |
| +81.4% |